Nonpharmacologic Interventions to Prevent & Treat Hypertension At-a-Glance

Find out how effective each of 8 ACC/AHA-recommended non-drug interventions is at reducing BP (in mm Hg) in adults with hypertension and normal BP.

Nonpharmacologic intervention is recommended for most US adults who have hypertension as defined by the 2017 American College of Cardiology/American Heart Association hypertension detection and treatment guidelines, ​ ie, 130-139/80-90 mm Hg.

According to the ACC/AHA guideline, the interventions in the slide show below may be sufficient to prevent hypertension as well as to help individuals with stage 1 hypertension meet blood pressure goals; they are integral to management of stage 2 hypertension in tandem with medication and recommended as the foundation of individual and population approaches to reducing risk of BP-related cardiovascular disease.

Each slide presents the type of intervention, recommended dose, and expected reduction in BP in adults with hypertension and those with normotension.

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
© 2023 MJH Life Sciences

All rights reserved.